Tata Mutual Fund bought 6.26 lakh shares of Biocon Limited for ₹25.04 Cr at ₹400.00 apiece in a block deal.
A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.
AMC subsidiary of the Tata Group, India's most diversified conglomerate. Manages over Rs 1.8 lakh crore with a wide range of equity, debt and hybrid schemes. Part of the broader Tata Capital financial services ecosystem. Tata Small Cap Fund and Tata Digital India Fund have been among the most popular thematic and segment-specific equity offerings.
